119 related articles for article (PubMed ID: 23222983)
1. [The optimal venous access for the chemotherapy in children].
Rykov MIu; Buĭdeniuk IuV
Khirurgiia (Mosk); 2012; (9):60-3. PubMed ID: 23222983
[TBL] [Abstract][Full Text] [Related]
2. [Use of implantable chemotherapy reservoirs. Experience at the Hotel-Dieu of France].
Antakly MC; Yazbeck P; Hayeck G; Yazigi A; Cherfane A
J Med Liban; 1992; 40(2):108-11. PubMed ID: 1339879
[TBL] [Abstract][Full Text] [Related]
3. Use of central venous catheters for prolonged venous access in cancer chemotherapy.
Rajoor BG; Charak BS; Banavali SD; Iyer RS; Saikia TK; Gopal R; Advani SH
J Assoc Physicians India; 1990 May; 38(5):340-2. PubMed ID: 2387816
[TBL] [Abstract][Full Text] [Related]
4. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
Ge F; Cang J; Xue ZG
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
[TBL] [Abstract][Full Text] [Related]
5. [Permanent venous access through a +portacath reservoir in patients receiving prolonged chemotherapy].
García H; Díaz R; Pablo Barés J; Nevah E; Fábrega JM
Rev Med Panama; 1994 Jan; 19(1):8-12. PubMed ID: 7938718
[TBL] [Abstract][Full Text] [Related]
6. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
[TBL] [Abstract][Full Text] [Related]
7. [Central venous access in pediatric patients. A 6-year experience].
Torramade Ribas J; Hernández Lizoáin JL; Benito Fernández C; González Fernández J; Balen Rivera E; Martínez Regueira F; Pardo Sánchez F; Cienfuegos Suárez JA
An Esp Pediatr; 1993 Mar; 38(3):251-4. PubMed ID: 8460845
[TBL] [Abstract][Full Text] [Related]
8. [Implanted venous access system in oncology. Review of 296 cases].
Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
[TBL] [Abstract][Full Text] [Related]
9. [Venous access devices in oncology].
Maňásek V; Soumarová R; Kociánová I; Maňásková M
Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
[TBL] [Abstract][Full Text] [Related]
10. [Port device central venous access in children with chronic renal disease--personal experience].
Szczepańska M; Szprynger K; Stoksik P; Morawiec-Knysak A; Adamczyk P; Ziora K; Oswiecimska J
Wiad Lek; 2006; 59(11-12):814-8. PubMed ID: 17427497
[TBL] [Abstract][Full Text] [Related]
11. [Implantable catheter systems].
Willnow U
Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
[TBL] [Abstract][Full Text] [Related]
12. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
13. A comparison of clinical outcomes with regular- and low-profile totally implanted central venous port systems.
Teichgräber UK; Streitparth F; Cho CH; Benter T; Gebauer B
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):975-9. PubMed ID: 19085032
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
Erhard J; Lange R; Kremens B; Krause U; Eigler FW
Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
[TBL] [Abstract][Full Text] [Related]
15. [Totally implantable vascular reservoir for chemotherapy: initial experience].
Cutait R; Averbach M; Borges JL; Carone E; Correa PA
AMB Rev Assoc Med Bras; 1990; 36(2):97-9. PubMed ID: 1965673
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic therapy. Role of durable venous access.
Rao VK; Charak BS; Giri NK; Banavali SD; Pai SK; Pai VR; Nadkarni KS; Kurkure PA; Saikia TK; Gopal R
J Assoc Physicians India; 1990 Dec; 38(12):897-9. PubMed ID: 2096122
[TBL] [Abstract][Full Text] [Related]
17. IR Approaches to Difficult Removals of Totally Implanted Venous Access Port Catheters in Children: A Single-Center Experience.
Patel PA; Parra DA; Bath R; Amaral JG; Temple MJ; John PR; Connolly BL
J Vasc Interv Radiol; 2016 Jun; 27(6):876-81. PubMed ID: 27106735
[TBL] [Abstract][Full Text] [Related]
18. Management of end-stage central venous access in children referred for possible small bowel transplantation.
Rodrigues AF; van Mourik ID; Sharif K; Barron DJ; de Giovanni JV; Bennett J; Bromley P; Protheroe S; John P; de Ville de Goyet J; Beath SV
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):427-33. PubMed ID: 16641582
[TBL] [Abstract][Full Text] [Related]
19. Interval between port catheter flushing can be extended to four months.
Ignatov A; Ignatov T; Taran A; Smith B; Costa SD; Bischoff J
Gynecol Obstet Invest; 2010; 70(2):91-4. PubMed ID: 20224280
[TBL] [Abstract][Full Text] [Related]
20. Totally implantable systems for intravenous drug delivery. Experiences in children with cancer.
van der Staak F; Bökkerink J; Lippens R; Severijnen R
Z Kinderchir; 1986 Feb; 41(1):39-42. PubMed ID: 3083618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
